Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome (Q30574939)

From Wikidata
Revision as of 23:12, 9 September 2023 by Emijrpbot (talk | contribs) (‎Changed label, description and/or aliases in pt, pt-br, da, fr: BOT - Fixing descriptions (4 languages): da, fr, pt, pt-br)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome
scientific article

    Statements

    Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome (English)
    Katherine V Barnes
    Heather M O'Leary
    Yaron Finkelstein
    Charles A Nelson
    Vanessa Vogel-Farley
    Geneva DeGregorio
    Umakanth Khatwa
    Mark E Alexander
    Deirdre M Finnegan
    Nicole G Cantwell
    Alexandra C Walco
    Leonard Rappaport
    Raina N Fichorova
    Michael W Shannon

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit